Sakys John 4

What Happened

• John Sakys, Chief Financial Officer of Mesa Laboratories (MLAB), exercised stock options to acquire 2,717 shares on 2026-06-15 by paying $104.08 per share (total cash paid $282,785). The same filing also shows the expiration of a short derivative position covering 3,951 shares and a related conversion/disposition line for 2,717 derivative units at $0.00. In addition, Mr. Sakys was granted 8,416 restricted stock units (RSUs) on that date (these RSUs are awarded, not immediately tradable shares).
• The exercise is an acquisition (insider paid strike price to get shares); the expired/disposed derivative items are routine derivative adjustments and the RSU grant is a standard equity award.

Key Details

• Transaction date: 2026-06-15 (Form 4 filed 2026-06-16 — appears timely).
• Option exercise: 2,717 shares acquired at $104.08 each; total cash outlay reported $282,785.
• Expiration: 3,951 shares — expiration of a short derivative position (no cash reported).
• Related conversion/disposition: 2,717 derivative units reported disposed at $0.00 (derivative line item in the filing).
• Award: 8,416 RSUs granted at $0.00 (each RSU represents a right to one share when vested).
• Shares owned following transactions: not specified in the provided summary of the filing.
• Notable footnotes:
  • F1: NSOs (nonqualified stock options) vested 1/3 on each anniversary of the June 15, 2020 grant.
  • F2: Each RSU converts to one share upon settlement.
  • F3 / F5: RSU vesting schedules: one series vests 1/3 on June 15, 2026 and yearly thereafter; another vests 34% on June 15, 2027, then 33% on June 8, 2028 and 33% on June 8, 2029.
  • F6: 50 shares are held in custodial accounts for Mr. Sakys’ children.
• No indication in the filing of an immediate open-market sale of the exercised shares.

Context

• Exercise of options (code M) means Mr. Sakys paid the option strike price to receive common shares. A separate derivative expiration (code E) indicates a derivative position lapsed. RSU grants (code A) are compensation awards that vest over time and do not necessarily reflect immediate market activity.
• These filings are factual disclosures of equity-related transactions by an executive; they do not, by themselves, explain the insider’s motives. Purchases/exercises show the insider acquired stock; awards and expirations are common parts of executive compensation and option lifecycle.